Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content

Healthcare & Pharmaceuticals

European Medicines Agency meeting early to discuss Moderna coronavirus vaccine

1 minute read

An employee shows the Moderna coronavirus disease (COVID-19) vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in New York, U.S., December 21, 2020. REUTERS/Eduardo Munoz

AMSTERDAM, Jan 4 (Reuters) - The European Medicines Agency was holding early meetings on Monday to discuss the Moderna vaccine against COVID-19, a spokesperson said.

EMA’s human medicines committee (CHMP) could issue an opinion on approving the vaccine later on Monday. Meetings had been scheduled for Wednesday.

Reporting by Anthony Deutsch; Editing by Jan Harvey

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters